文献速递乳腺CTMR乳腺X线

对比增强锥光束乳腺CT(CBBCT):与乳腺X线摄影和MRI的临床性能比较

Contrast-enhanced cone-beam breast-CT (CBBCT): clinical performance compared to mammography and MRI.
PubMed 文献 · Eur Radiol · 2018-03-28

前瞻性研究纳入41例女性(52侧乳腺,ACR密度c或d类,MG或US评估BI-RADS 4或5类),比较CE-CBBCT与NC-CBBCT、MG和MRI的诊断准确性。CE-CBBCT的AUC和敏感度优于MG和NC-CBBCT,与MRI在致密乳腺中相当;敏感度低于MRI但特异度数值上高于MRI。

要点

  • CE-CBBCT在致密乳腺中AUC与MRI相当,优于MG和NC-CBBCT。
  • CE-CBBCT敏感度较MG提高37-39%,但低于MRI。
  • CE-CBBCT特异度数值上高于MRI,但差异未达统计学显著。

核心结论

  • CE-CBBCT诊断性能随阅片者及其经验变化;在致密乳腺中,CE-CBBCT较MG和NC-CBBCT提高AUC和敏感度,与MRI相当;特异度趋势上高于MRI。

研究设计与样本

  • 前瞻性、经机构审查委员会批准的研究,纳入41例女性共52侧乳腺,ACR乳腺密度c或d类且MG或US评估为BI-RADS 4或5类;由两名盲法阅片者独立评估各影像模态。

诊断标准与关键数值

  • CE-CBBCT诊断准确性AUC:阅片者1为0.83,阅片者2为0.77。
  • MRI诊断准确性AUC:阅片者1为0.88,阅片者2为0.89;CE-CBBCT vs MRI的p值分别为0.2272和0.002。
  • NC-CBBCT诊断准确性AUC:阅片者1为0.73,阅片者2为0.66;CE-CBBCT vs NC-CBBCT的p值分别为0.038和0.0186。
  • MG诊断准确性AUC:阅片者1为0.69,阅片者2为0.64;CE-CBBCT vs MG的p值分别为0.081和0.0207。
  • CE-CBBCT敏感度:阅片者1为0.88,阅片者2为0.78;MG敏感度:阅片者1为0.49,阅片者2为0.41;CE-CBBCT较MG提高37-39%,p均<0.001;MRI敏感度:阅片者1为0.98,阅片者2为0.96;CE-CBBCT vs MRI的p值分别为0.0253和0.0027。

临床应用与阅片要点

  • CE-CBBCT可作为有MRI禁忌证患者的潜在影像替代选择。

局限性

  • CBBCT诊断性能随各自阅片者及其经验而变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the diagnostic accuracy of contrast-enhanced (CE) cone-beam breast computed tomography (CBBCT) in dense breast tissue and compare it to non-contrast (NC) CBBCT, mammography (MG) and magnetic resonance imaging (MRI).

METHODS: This prospective institutional review board-approved study included 41 women (52 breasts) with American College of Radiology (ACR) density types c or d and Breast Imaging Reporting and Data System (BI-RADS) 4 or 5 assessments in MG or ultrasound (US). Imaging modalities were independently evaluated by two blinded readers.

RESULTS: A total of 100 lesions (51 malignant, 6 high-risk, and 43 benign) were identified. For readers 1/2, respectively, and p values comparing CE-CBBCT to other modalities: diagnostic accuracy (AUC) for CE-CBBCT was 0.83/0.77, for MRI 0.88/0.89 (p = 0.2272/0.002), for NC-CBBCT 0.73/0.66 (p = 0.038/ 0.0186) and for MG 0.69/0.64 (p = 0.081/0.0207). CE-CBBCT sensitivity (0.88/0.78) was 37-39% higher in comparison to MG (0.49/0.41, p < 0.001 both) but inferior to MRI (0.98/0.96, p = 0.0253/0.0027). CE-CBBCT specificity (0.71/0.71) was numerically higher compared to MRI (0.61/0.69, p = 0.0956/0.7389).

CONCLUSIONS: CBBCT diagnostic performance varied with the respective reader and experience. CE-CBBCT improved AUC and sensitivity in comparison to MG and NC-CBBCT, and was comparable to MRI in dense breast tissue. In tendency, specificity was higher for CE-CBBCT than MRI.

KEY POINTS: • CE-CBBCT diagnostic accuracy (AUC) was comparable to MRI in dense breasts. • CE-CBBCT improved sensitivity and AUC in comparison to MG and NC-CBBCT. • CE-CBBCT has inferior sensitivity but higher specificity than MRI. • CE-CBBCT is a potential imaging alternative for patients with MRI contraindications.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Wienbeck S, Fischer U, Luftner-Nagel S, et al. Contrast-enhanced cone-beam breast-CT (CBBCT): clinical performance compared to mammography and MRI. Eur Radiol. 2018. PMID: 29594402. doi:10.1007/s00330-018-5376-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。